AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing targeted alpha therapies (TAT) for cancer, built around lead-212 (Pb-212) alpha-emitting isotopes and a proprietary, scalable isotope production and supply chain. Its lead candidate, 212Pb-ADVC001, is in clinical development for metastatic prostate cancer, and the company operates GMP radiochemistry and sterile manufacturing capability across Sydney, Brisbane (Translational Research Institute and Richlands) and Adelaide in Australia, with a global headquarters established in the Greater Boston area. AdvanCell is a private, venture-backed biotechnology company; it publishes no public developer program, API, or machine-readable API contract.
AdvanCell is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Health, and Oncology.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/advancell/"><img src="https://apis.io/badge/advancell/card.svg" alt="AdvanCell on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
12 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: advancell
name: AdvanCell
description: AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing targeted alpha therapies
(TAT) for cancer, built around lead-212 (Pb-212) alpha-emitting isotopes and a proprietary, scalable isotope production
and supply chain. Its lead candidate, 212Pb-ADVC001, is in clinical development for metastatic prostate cancer, and the
company operates GMP radiochemistry and sterile manufacturing capability across Sydney, Brisbane (Translational Research
Institute and Richlands) and Adelaide in Australia, with a global headquarters established in the Greater Boston area. AdvanCell
is a private, venture-backed biotechnology company; it publishes no public developer program, API, or machine-readable API
contract.
url: https://raw.githubusercontent.com/api-evangelist/advancell/refs/heads/main/apis.yml
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- rate-limits
- security
generated: '2026-11-06'
method: derived
image: https://www.advancell.com.au/wp-content/uploads/2025/04/advancell-og-image.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: no-public-api
x-tier-reason: 'Enrichment pass 2026-09-09: clinical-stage biotech, no developer program or machine-readable API contract
on any host probed.'
specificationVersion: '0.20'
created: '2026-09-09'
modified: '2026-09-09'
position: Producing
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Health
- Oncology
- Radiopharmaceuticals
- Life Sciences
- Clinical Trials
- Australia
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-09-09'
status: minimal
artifacts_added: 5
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: AdvanCell is a private clinical-stage radiopharmaceutical developer whose entire public surface is an eleven-page
WordPress marketing site (Home, Company, Partners and Investors, News, Contact, four policy pages, ESMO2025, coming-soon)
with no developer, docs or api subdomain and no product to integrate with; every OpenAPI/GraphQL/well-known/agent-card
path probed on www.advancell.com.au returned 404, and the only JSON endpoint on the domain is the default WordPress core
/wp-json/ route index, which is a CMS default rather than a published API.
evidence:
- url: https://www.advancell.com.au/openapi.json
status: 404
- url: https://www.advancell.com.au/.well-known/agent-card.json
status: 404
- url: https://www.advancell.com.au/graphql
status: 404
- url: https://www.advancell.com.au/llms.txt
status: 404
- url: https://www.advancell.com.au/wp-json/
status: 200
- url: https://www.advancell.com.au/page-sitemap.xml
status: 200
checked: '2026-09-09'
common:
- type: DomainSecurity
url: security/advancell-domain-security.yml
- type: Website
url: https://www.advancell.com.au/
- type: About
url: https://www.advancell.com.au/company/
- type: Newsroom
url: https://www.advancell.com.au/news/
- type: Contact
url: https://www.advancell.com.au/contact/
- type: InvestorRelations
url: https://www.advancell.com.au/partners-and-investors/
- type: Careers
url: https://jobs.lever.co/advancell
- type: TermsOfService
url: https://www.advancell.com.au/terms/
- type: PrivacyPolicy
url: https://www.advancell.com.au/privacy/
- type: x-cookie-policy
url: https://www.advancell.com.au/cookies/
- type: x-acceptable-use-policy
url: https://www.advancell.com.au/acceptable-use/
- type: LinkedIn
url: https://www.linkedin.com/company/advancell/
- type: LLMsTxt
url: llms/advancell-llms.txt
- type: Plans
url: plans/advancell-plans-pricing.yml
- type: RateLimits
url: rate-limits/advancell-rate-limits.yml
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.